Last reviewed · How we verify

NCT04684173

A Preliminary Study on Artificial Intelligence for Infant Motor Screening

Completed Last updated 14 September 2022
What this trial tests

trial in Motor Disorders in 47 participants. Completed in 31 December 2021.

Timeline
17 November 2020
Primary endpoint
30 March 2021
31 December 2021

Quick facts

Lead sponsorNational Taiwan University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment47
Start date17 November 2020
Primary completion30 March 2021
Estimated completion31 December 2021
Sites1 location across Taiwan

Conditions studied

Sponsor

National Taiwan University Hospital

Who can join

Adults 4 Months to 18 Months, any sex, with Motor Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this preliminary study is to apply AI technology on a sample of infants aged 4 to 18 months to develop an action tracking and recognition algorithm for infant motor screening and to determine the accuracy of the captured movements during the Alberta Infant Motor Scale (AIMS) assessment using an experienced physical therapists' assessment results as the reference.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Motor Disorders

Currently open trials in the same condition.

Other National Taiwan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04684173.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing